Blinatumomab-induced remission of refractory immune thrombocytopenia in pediatric acute lymphoblastic leukemia: a case report

Key Points

• The aim is to present the effects of blinatumomab on resistant immune thrombocytopenia in a pediatric patient with acute lymphoblastic leukemia.
• Case report analysis of a single pediatric patient
• Documentation of treatment regimen and response to therapy
• Assessment of hematologic parameters
• Blinatumomab treatment led to the resolution of immune thrombocytopenia
• Significant improvement in platelet counts observed
• Potentially effective alternative treatment identified for challenging cases